Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean G Tang

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
The Journal of Biological Chemistry|April 22, 2003
Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variantsBobby Bhatia, Carlos J Maldonado, Shaohua Tang, et al.
Oncotarget|July 23, 2016
miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cellsRuifang Liu, Can Liu, Dingxiao Zhang, et al.
The Prostate|May 27, 2016
Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate CancerLeigh Ellis, ShengYu Ku, Qiuhui Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cellsKiera Rycaj, Joshua B Plummer, Bingnan Yin, et al.
Oncotarget|September 9, 2017
Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse modelBigang Liu, Shuai Gong, Qiuhui Li, et al.
Nature Communications|May 1, 2020
Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancerDingxiao Zhang, Qiang Hu, Xiaozhuo Liu, et al.
International Journal of Cancer|December 7, 2007
Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERTBobby Bhatia, Asha S Multani, Lubna Patrawala, et al.
Oncotarget|February 13, 2016
Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-/lo castration-resistant cellsKiera Rycaj, Eun Jeong Cho, Xin Liu, et al.
Nature Communications|January 24, 2017
MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genesCan Liu, Ruifang Liu, Dingxiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 19, 2026
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancersFengzhi Li, Xiang Ling, Sayan Chakraborty, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|April 22, 2003
Subcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variantsBobby Bhatia, Carlos J Maldonado, Shaohua Tang, et al.
Oncotarget|July 23, 2016
miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cellsRuifang Liu, Can Liu, Dingxiao Zhang, et al.
The Prostate|May 27, 2016
Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate CancerLeigh Ellis, ShengYu Ku, Qiuhui Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cellsKiera Rycaj, Joshua B Plummer, Bingnan Yin, et al.
Oncotarget|September 9, 2017
Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse modelBigang Liu, Shuai Gong, Qiuhui Li, et al.
Nature Communications|May 1, 2020
Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancerDingxiao Zhang, Qiang Hu, Xiaozhuo Liu, et al.
International Journal of Cancer|December 7, 2007
Evidence that senescent human prostate epithelial cells enhance tumorigenicity: cell fusion as a potential mechanism and inhibition by p16INK4a and hTERTBobby Bhatia, Asha S Multani, Lubna Patrawala, et al.
Oncotarget|February 13, 2016
Longitudinal tracking of subpopulation dynamics and molecular changes during LNCaP cell castration and identification of inhibitors that could target the PSA-/lo castration-resistant cellsKiera Rycaj, Eun Jeong Cho, Xin Liu, et al.
Nature Communications|January 24, 2017
MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genesCan Liu, Ruifang Liu, Dingxiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 19, 2026
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancersFengzhi Li, Xiang Ling, Sayan Chakraborty, et al.
Pageof 14